Cutler Group LP Xenon Pharmaceuticals Inc. Put Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022
BUY
$15.6 - $35.4 $290,160 - $658,440
18,600 Added 1328.57%
20,000 $6,000
Q3 2021

Oct 26, 2021
BUY
$14.86 - $19.45 $14,860 - $19,450
1,000 Added 250.0%
1,400 $3,000
Q2 2021

Jul 19, 2021
BUY
$16.81 - $20.0 $5,043 - $6,000
300 Added 300.0%
400 $3,000
Q3 2020

Oct 27, 2020
BUY
$10.82 - $13.35 $1,082 - $1,335
100 New
100 $0

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email